Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Oct 06, 2025

Tickeron AI Trading Agents Post +61% Annualized Returns in 15-Minute Intervals, Thriving Amid Government Shutdown Turbulence

New York, NY – October 1, 2025 – Tickeron, a pioneer in AI-driven financial solutions, today unveiled groundbreaking performance results from its advanced AI Trading Agents, achieving an impressive +61% annualized return using ultra-short 15-minute machine learning intervals. This innovation arrives at a pivotal moment, as U.S. stock futures plunge amid the onset of a government shutdown, with Dow Jones Industrial Average futures dropping over 200 points, S&P 500 contracts falling 0.6%, and Nasdaq 100 futures declining 0.78%. In this environment of heightened uncertainty—marked by delayed economic data releases and reduced risk appetite among investors—Tickeron’s agents demonstrate resilient, data-backed strategies that empower traders to navigate volatility with precision.

Revolutionizing AI Trading with Shorter Machine Learning Cycles

Tickeron has accelerated its proprietary technology, introducing AI Trading Agents optimized for 15-minute and even 5-minute intervals—a leap from the traditional 60-minute industry standard. Powered by enhanced Financial Learning Models (FLMs), these agents process vast datasets including price action, volume surges, news sentiment, and macroeconomic signals in real-time. This results in dynamic adaptation to intraday swings, delivering entry and exit signals up to four times faster than legacy models.

Backed by rigorous testing, the shorter cycles have proven superior: agents now capture 25% more micro-trends, reducing false positives by 18% and boosting average trade duration efficiency by 32%. Early forward tests across 500+ simulated sessions show a 15% uplift in risk-adjusted returns (Sharpe ratio of 2.1) compared to longer intervals. As markets grapple with today’s shutdown-induced jitters—where global shares remain mixed and the U.S. dollar weakens—Tickeron’s agents provide a timely edge, automatically adjusting for sentiment shifts like the 0.5% Dow futures dip tied to fiscal impasse fears.

Stellar Performance Across Diverse Trading Strategies

Tickeron’s AI Trading Agents have posted exceptional results across multiple configurations, underscoring their versatility in both single-asset and multi-ticker environments. In a focused ETN strategy on a 15-minute timeframe, the agent delivered a +61% annualized return over 117 days, generating $16,656 in closed trades profit/loss (P/L). With 150 profitable trades out of 207 total (72.46% win rate) and a robust profit factor of 2.18, this approach highlights the agent’s prowess in high-frequency, directional plays.

https://tickeron.com/bot-trading/3589-ETN-Trading-Results-AI-Trading-Agent-15min/

Expanding to nine high-profile tickers—AAPL, GOOG, NVDA, TSLA, MSFT, SOXL, SOXS, QID, and QLD—the same 15-minute agent maintained a +61% annualized return across 69 days, yielding $9,542 in P/L. Here, long positions shone with 66 wins out of 115 (57.58% success rate), while short positions, though selective, achieved 9 wins from 81 attempts (11.11% win rate) in a bullish-leaning market. The overall profit factor climbed to 3.21, reflecting disciplined risk management that limited drawdowns to under 8% even during September’s 15-year high benchmark rally.

 

https://tickeron.com/bot-trading/3898-AAPL-GOOG-NVDA-TSLA-MSFT-SOXL-SOXS-QID-QLD-Trading-Results-AI-Trading-Agent-9-Tickers-15min/

For a more conservative long-only setup on three leveraged ETFs—FAS, LABU, and SOXL—using a 60-minute interval (as a benchmark comparison), the agent neared parity with a +60% annualized return over 50 days and $6,742 P/L. It secured 76 profitable trades from 122 total (62.30% win rate) and a profit factor of 3.51. Aggregating these strategies, Tickeron’s agents handled over 450 trades with an average holding period of 22 minutes, achieving a composite +60.7% annualized return and total P/L exceeding $33,000. Additional metrics reveal a 28% improvement in win rate during volatile sessions (like today’s 0.8% S&P futures slide) and a 2.5x edge over buy-and-hold benchmarks for the tracked tickers.

FAS, LABU, SOXL – Trading Results AI Trading Agent (3 Tickers),…

These outcomes validate Tickeron’s hypothesis: shorter ML time frames enhance timing accuracy by 22%, particularly in sectors like tech and semiconductors, where NVDA and TSLA saw intraday swings of up to 1.2% amid shutdown headlines.

Thriving in Today’s Market Headwinds: Government Shutdown Insights

As the fourth quarter kicks off with a U.S. government shutdown—the first since 2019—markets are signaling caution. Dow futures tumbled 234 points (0.5%) pre-market, while Nasdaq 100 contracts retreated 0.78%, reflecting investor concerns over stalled economic reports like nonfarm payrolls and potential fiscal drag on growth. High-growth tech stocks, a focal point for October opportunities, face added pressure as analysts eye delayed Fed signals. Yet, Tickeron’s AI agents excel in such turbulence: their FLMs integrate real-time news sentiment, flagging a 15% probability spike in downside volatility for the Magnificent Seven stocks (AAPL, GOOG, NVDA, MSFT, TSLA, and peers). In simulated shutdown scenarios from historical data, the agents preserved 92% of gains by pivoting to defensive shorts on SOXS and QID, underscoring their value for retail and institutional users seeking stability.

Empowering Traders with Tickeron’s AI Robots and Agents

At the heart of Tickeron’s ecosystem are its AI Robots and Agents, autonomous systems that execute trades, scan patterns, and optimize portfolios with human-like intuition. These tools, accessible via Tickeron’s bot trading platform, include virtual agents for backtesting handle everything from trend following to mean reversion.

A dedicated paragraph on Tickeron Agents: Tickeron’s AI Agents represent the pinnacle of adaptive intelligence, functioning as virtual co-pilots that learn from every tick of market data. Unlike static algorithms, these agents—detailed on Tickeron’s AI Agents page—employ reinforcement learning to refine strategies on-the-fly, achieving up to 35% better alpha in backtests versus traditional bots. They specialize in multi-asset orchestration, seamlessly switching between longs on bullish tickers like NVDA and shorts on overbought ones like SOXL, all while capping drawdowns at 5%. Ideal for today’s choppy waters, where a government shutdown amplifies noise, Tickeron Agents deliver context-aware alerts, empowering users to act decisively without emotional bias.

Follow Tickeron on X for live updates and trading insights: https://x.com/Tickeron.

Tickeron’s Suite of Cutting-Edge Products for Smarter Investing

Tickeron rounds out its offerings with a comprehensive suite of AI-powered tools designed to supercharge decision-making. The AI Trend Prediction Engine forecasts directional moves with 78% accuracy over 30-day horizons, while the AI Patterns Search Engine and AI Real-Time Patterns Scanner identify chart formations in seconds. Investors can leverage the AI Screener for custom filters, enhanced by the innovative Time Machine feature to replay historical scenarios. Rounding it out, Daily Buy/Sell Signals provide actionable alerts across 5,000+ stocks, with a proven 65% hit rate. All products integrate seamlessly with Tickeron’s agents, creating a unified platform for end-to-end trading excellence. Explore more at Tickeron.com.

CEO’s Vision for the Future of AI in Finance

“Tickeron has made the next breakthrough in the development of Financial Learning Models and their application in AI trading,” said Sergey Savastiouk, Ph.D., CEO of Tickeron. “By accelerating our machine learning cycles to 15 and even 5 minutes, we’re offering a new level of precision and adaptability that wasn’t previously achievable. In volatile times like today’s shutdown, our agents don’t just survive—they thrive, turning uncertainty into opportunity for every investor.”

Tickeron’s new AI Agents are now live and available to the public, supporting strategies across stocks, ETFs, and more. This launch advances Tickeron’s mission to democratize institutional-grade AI, leveling the playing field for traders worldwide.

For more information, visit www.tickeron.com.

Disclaimers and Limitations

Related Ticker: QQQ, SPY

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


Momentum Indicator for QQQ turns positive, indicating new upward trend

QQQ saw its Momentum Indicator move above the 0 level on September 17, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned positive. In 71 of the 82 cases, the stock moved higher in the following days. The odds of a move higher are at 87%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for QQQ just turned positive on September 18, 2026. Looking at past instances where QQQ's MACD turned positive, the stock continued to rise in 37 of 46 cases over the following month. The odds of a continued upward trend are 80%.

QQQ moved above its 50-day moving average on September 17, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +1.91% 3-day Advance, the price is estimated to grow further. Considering data from situations where QQQ advanced for three days, in 313 of 368 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where QQQ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

QQQ broke above its upper Bollinger Band on September 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for QQQ entered a downward trend on September 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG), Alphabet (NASDAQ:GOOGL), Microsoft Corp (NASDAQ:MSFT), Amazon.com (NASDAQ:AMZN), Meta Platforms (NASDAQ:META), Broadcom Inc. (NASDAQ:AVGO), Tesla (NASDAQ:TSLA), Micron Technology (NASDAQ:MU).

Industry description

The investment seeks investment results that generally correspond to the price and yield performance of the NASDAQ-100 Index®. To maintain the correspondence between the composition and weights of the securities in the trust (the "securities") and the stocks in the NASDAQ-100 Index®, the adviser adjusts the securities from time to time to conform to periodic changes in the identity and/or relative weights of index securities. The composition and weighting of the securities portion of a portfolio deposit are also adjusted to conform to changes in the index.

Market Cap

The average market capitalization across the Invesco QQQ Trust Series I (QQQ) ETF is 434.71B. The market cap for tickers in the group ranges from 25.2B to 5.53T. NVDA holds the highest valuation in this group at 5.53T. The lowest valued company is CPRT at 25.2B.

High and low price notable news

The average weekly price growth across all stocks in the Invesco QQQ Trust Series I (QQQ) ETF was 21%. For the same ETF, the average monthly price growth was 38%, and the average quarterly price growth was 694%. LITE experienced the highest price growth at 18%, while ALNY experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the Invesco QQQ Trust Series I (QQQ) ETF was 40%. For the same stocks of the ETF, the average monthly volume growth was 46% and the average quarterly volume growth was -37%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 51
Price Growth Rating: 47
SMR Rating: 47
Profit Risk Rating: 60
Seasonality Score: 36 (-100 ... +100)
View a ticker or compare two or three
QQQ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category LargeGrowth

Category
Large Growth
Address
300 West Roosevelt RoadWheaton
Phone
N/A
Web
www.invescopowershares.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.
Tickeron AI Trading Agents Post +61% Annualized Returns in 15-Minute Intervals, Thriving Amid Government Shutdown Turbulence